Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Cooper Companies, Inc.

Close the acquisition of Cook Medical's Reproductive Health business

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
7 Feb 2022
Due
30 Apr 2022
Checked
10 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Expected to close in fiscal Q2 2022”

What we found

Evidence strength A What the grades mean

The deal had not closed by the April 30, 2022 deadline; June and August 2022 filings describe it as pending regulatory approval, and a 2023 filing references a termination fee under the purchase agreement.

  • A
    Cooper Companies (The) 8-K filed 2022-06-02 Regulatory filing · published 2 Jun 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint f6de5aba3626
    “as the transaction is pending regulatory approval.” ✓ confirmed on the page
  • A
    Cooper Companies (The) 8-K filed 2022-08-31 Regulatory filing · published 31 Aug 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 686a7805cc3f
    “Fiscal year 2022 financial guidance does not include the Cook Medical Reproductive Health acquisition announced on February 7, 2022, as the transaction is pending regulatory approval.” ✓ confirmed on the page
  • A
    Cooper Companies (The) 10-Q filed 2023-06-02 Regulatory filing · published 2 Jun 2023 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 5904509fef3e
    “primarily due to an accrual of $45.0 million associated with the probable payment in August 2023 of a termination fee under an asset purchase agreement related to Cook Medical’s reproductive health business” ✓ confirmed on the page

Market reaction: the shares moved -0.1% against the S&P 500 over the three sessions around the disclosure (1 Jun 2022 to 6 Jun 2022). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Acquisition close
Indicative materiality
High rules
Action
Close
Deliverable
Cook Medical's Reproductive Health business
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: subject to customary closing conditions, including entry into a definitive acquisition agreement and regulatory approvals, and compliance with local consultatio
Depends on
Regulatory, Partner

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesGemini (Google) re-read the evidence blind and read it as “Withdrawn”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Cooper Companies (The)? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2022-COO-005499 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.